[1] THANOU-STAVRAKI A,JAMES JA. Primary Sjogren’s syndrome:current and prospective therapies[J]. Semin Arthritis Rheum,2008,37(5):273-292. [2] KASSAN SS,MOUTSOPOULOS HM. Clinical manifestations and early diagnosis of Sjögren syndrome[J]. Arch Intern Med,2004,164(12):1275-1284. [3] MORI K,IIJIMA M,KOIKE H,et al. The wide spectrum of clinical manifestations in Sjögren’s syndrome-associated neuropathy[J]. Brain,2005,128(Pt 11):2518-2534. [4] GAUBITZ M. Epidemiology of connective tissue disorders[J]. Rheumatology (Oxford),2006,45 (Suppl 3):iii3-4. [5] XIANG YJ,DAI SM. Prevalence of rheumatic diseases and disability in China[J]. Rheumatol Int,2009,29(5):481-490. [6] RAMOS-CASALS M,FONT J. Primary Sjögren’s syndrome:current and emergent aetiopathogenic concepts[J]. Rheumatology (Oxford),2005,44(11):1354-1367. |